Cuccurazzu B, et al
pilot study (BMC Gastroenterol, 2017, PMC5548760) found that 300 mg/day oral glutathione for 4 months reduced ALT and liver fat markers in 29 NAFLD patients
Nausea was reported by 28.6%, 38.4%, and 42.4% of participants in the 4 mg, 9 mg, and 12 mg groups, respectively, compared with 14.8% receiving placebo
Pooled data show creatine adds roughly 1.1 kg of lean mass beyond resistance training alone (Nutrients, 2025)
This aging mechanism is closely related to various common diseases, including atherosclerosis, hypertension, chronic obstructive pulmonary disease, diabetes, and neurodegenerative disorders (Ying et al., 2024)
These results demonstrate that tirzepatide is associated with a higher percentage of patients achieving significant, clinically meaningful weight loss thresholds compared to semaglutide